A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis

NCT02627768 · clinicaltrials.gov ↗

COMPLETED

Status

991

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriatic Arthritis

Interventions

DRUG: No Intervention

Sponsor

Janssen Pharmaceutica N.V., Belgium